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Microscopic Polyangiitis Presenting With A Pure Sensory Peripheral Symmetric Polyneuropathy
Matthew J. Sullivan DO, Craig A. Mackaness DO, and James Ross MD
Department of Internal Medicine, Lehigh Valley Health Network, Allentown, Pennsylvania

Case Presentation

Background
• Microscopic polyangiitis (MPA) is a systemic small-vessel
necrotizing vasculitis with a strong association with antimyeloperoxidase anti-neutrophilic cytoplasmic antibodies
(MPO-ANCA). MPA has little or no immune deposit and is
not associated with granulomatous inflammation.1
• In most cases MPA presents with rapidly progressive
necrotizing glomerulonephritis and occasionally with
pulmonary hemorrhage.2 Over 70% of patients have
constitutional symptoms at diagnosis and disease
manifestations may involve any organ system.3 MPA may
also present without renal or pulmonary involvement.2,4
• Peripheral neuropathy has frequently been reported as a
symptom of ANCA-associated vasculitis and is commonly
present at disease onset. It may also be an initial
manifestation of the disease state, but there is limited
evidence comparing the incidence of neuropathy with the
other manifestations of systemic vasculitides.1,4,5
• Studies have shown that a majority of those with ANCAassociated vasculitis report peripheral neuropathy at some
point in the disease process, but less than 25% report
it at initial presentation. Among the ANCA-associated
vasculitides, MPA appears to have the lowest incidence of
reported peripheral neuropathy; sensory or motor.1,5
• A recent case report of MPA presents a patient with lower
extremity polyneuropathy preceding renal manifestations.6
• MPA is treated in two phases: Induction phase is
acute treatment with systemic corticosteroids and
immunosuppressive agents such as cyclophosphamide
or rituximab. Maintenance phase begins 1-2 months
after resolution of inflammation and typically involves
azathioprine.7,8 Patients may also be treated with plasma
exchange during induction phase.2,8
First
Admission

Second
Admission

11.1 / 33

Hemoglobin / Hematocrit

6.2 / 18.1

1.47

Serum Creatinine

5.89

100

ESR

125

2.2

CRP

10.3

780

Rheumatoid Factor

584

CCP Antibody

Negative

Negative

ANA Panel with Reflex

Negative

Negative

Lyme Titer

6.3%

HgbA1c

5.9%

ASO Titer

27 (Ref. <240)

Hepatitis/HIV Screen

Negative

ACE Level

29 (Ref. <20)

PR3-ANCA (c-ANCA)

6.2 (Ref. <20)

MPO-ANCA (p-ANCA)

148 (Ref. <20)

Anti-GBM

Negative

Cryoglobulins

Negative

SPEP Interpretation

Polyclonal
hypergammaglobulinemia

Chronic Inflammatory
Stress Response

Table 1. Selected laboratory values from two hospital admissions.  
Hemoglobin/Hematocrit and serum creatinine are from initial
presentations.

A 58 year old woman without significant past medical history presented with the
chief complaints of weakness and loss of balance. She described a weakness
and heaviness of her bilateral lower extremities and felt off-balance with difficulty
ambulating. She also described a clumsiness and inability to correctly use her left
hand.
This occurred in the context of a one year history of “pins and needles” sensation in
her bilateral feet.
Physical exam revealed a stocking-glove distribution of decreased pinprick
sensation, decreased vibration sense in the bilateral toes, ataxic gait, and a positive
Romberg sign. The patient underwent extensive imaging revealing the following
results:
• CT Head: no acute abnormality
• MRA Head/Neck: 50% stenosis of proximal right ICA, 75% stenosis of left ICA,
both felt to be artifactual
• MRI Brain: scattered foci of non-specific supratentorial white matter signal
abnormality, but no acute abnormality
• Chest XR: interstitial prominence laterally at both lung bases most likely
represents chronic interstitial disease
• 2D ECHO: aneurysmal interatrial septum without evidence of shunt, EF 60%
• CT Chest: interstitial lung disease, mild mediastinal and hilar adenopathy, mild
honeycombing at bilateral bases
• CT Abd/Pelvis: 6cm cystic right pelvis mass, representing likely ovarian cyst
Laboratory studies revealed an elevated erythrocyte sedimentation rate (ESR)
and C-reactive protein (CRP), positive rheumatoid factor (RF), and elevated serum
creatinine. Patient was ultimately discharged home with a diagnosis of peripheral
neuropathy likely secondary to thiamine deficiency.
Three months after discharge the patient presented with the acute onset of
substernal chest pain exacerbated by inspiration and associated with shortness of
breath.
Initial laboratory examination revealed marked acute oligoanuric renal failure,
proteinuria, anemia, and new diffuse bilateral perihilar infiltrates on chest xray and CT. Bronchoscopy revealed acute alveolar hemorrhage. Further
laboratory studies demonstrated elevated anti-myeloperoxidase anti-neutrophilic
cytoplasmic antibodies (MPO-ANCA). The patient then underwent renal biopsy
which revealed acute and chronic pauci-immune necrotizing, sclerosing, and
crescentic glomerulonephritis associated with focal necrotizing vasculitis; typical of
changes seen with MPO-ANCA seropositivity, leading to a diagnosis of microscopic
polyangiitis.
The patient was initiated on hemodialysis due to her rapidly progressive
glomerulonephritis. She was treated with pulse dose methylprednisolone followed
by stress dose prednisone, as well as therapeutic plasma exchange and oral
cyclophosphamide. Her maintenance phase included azathioprine and prednisone.
Her peripheral neuropathy persists despite treatment. She remains dialysis
dependent despite two weaning attempts and is currently undergoing transplant
evaluation.

Discussion

Figure 1. Chest x-ray from
second admission showing new
diffuse bilateral perihilar opacities.

Figure 2. CT of the chest from
second admission demonstrating
alveolar groundglass opacities
and air bronchograms.

Our case is a rare presentation of microscopic polyangiitis (MPA)
with concurrent diffuse alveolar hemorrhage and dialysis dependent
rapidly progressive glomerulonephritis in the setting of long-standing
bilateral stocking-glove distribution pure sensory symmetric peripheral
neuropathy.
Previous literature has demonstrated that a majority of those with
ANCA-associated vasculitis report peripheral neuropathy at some point
in the disease process, but few had active vasculitic neuropathy at
baseline.
Patients with vasculitic nephropathy at baseline have a higher median
number of organ systems involved when compared with those without
neuropathy, and also reported higher Birmingham Vasculitis Activity
Scores, which is a clinical checklist of items organized by organ system
used to determine disease activity.
The European Vasculitis Study Group trials showed that a pure sensory
neuropathy, which our patient developed early in her disease course,
was not reported in any patients with MPA. However, our patient did
not undergo electrophysiologic confirmation of her neuropathy.
Studies demonstrate that non-specific symptoms may be present for
months to years prior to diagnosis of MPA. This case demonstrates
the difficulty of recognizing MPA when only a single organ system
is involved and that ANCA-associated vasculitis should be included
on the differential diagnosis of peripheral neuropathy with unclear
etiology. It also exemplifies the need for further research on peripheral
neuropathy in systemic vasculitides, specifically in MPA where these
early presenting signs have previously shown to be less prevalent.
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Figure 3. Light microscopy
of renal biopsy demonstrating
crescentic glomerulonephritis.
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Figure 4. Light microscopy
of kidney biopsy again
demonstrating compression of the
glomerulus by a cellular crescent.
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